Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Blood|October 1, 1995
CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosisE Ayroldi, L Cannarile, G Migliorati, et al.
Natural Immunity|November 1, 1992
Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cellsE Ayroldi, L Cannarile, F D'Adamio, et al.
Journal of Biological Response Modifiers|February 1, 1990
In vivo effects of cytokines on development of natural killer cells and antitumor activity in lethally irradiated bone marrow transplanted recipientsC Riccardi, G Migliorati, L Cannarile, et al.
Blood|May 15, 1997
CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L systemE Ayroldi, G Migliorati, L Cannarile, et al.
International Journal of Cancer|October 15, 1986
Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cellsC Riccardi, A Giampietri, G Migliorati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursorsG Migliorati, L Cannarile, R B Herberman, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
IL-2 induces and altered CD4/CD8 ratio of splenic T lymphocytes from transgenic mice overexpressing the glucocorticoid-induced protein GILZN Pozzesi, S Gizzi, F Gori, et al.
Blood|July 27, 2001
Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaBE Ayroldi, G Migliorati, S Bruscoli, et al.
Blood|December 3, 1998
Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell deathE Ayroldi, O Zollo, L Cannarile, et al.
Immunity|January 16, 1998
A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell deathF D'Adamio, O Zollo, R Moraca, et al.
Pageof 3